Apply These Secret Techniques To Improve Organ-on-chip Market

High Focus on Improved Drug Screening and growing applications of organ-on-chip

• The surge in demand for organ-on-chip devices in the healthcare industry is expected to boost the growth of the global organ-on-chip market. Real-time imaging, in-vitro analysis of biochemical, and genetic & metabolic activities of living cells in functional tissues are some of the applications of organ-on-chip devices in the industry. 
• Advancements in cell biology, microfabrication, and microfluidics have led to an increase in the adoption of organ-on-chips, thereby fueling the growth of the market. 
• Drug screening is a cost-effective method used to rapidly review all samples. 
• Scientists and researchers use organon-chip culture devices to monitor the effects of drugs in the body. 
• Furthermore, drug toxicity or drug effectiveness in various organs of the body is monitored using this technique. 
• Such tissue chips for drug screening programs aim to develop bioengineered devices to improve the process of predicting whether drugs will be safe or toxic for humans. 

Growing demand for kidney and lung organs on chip devices

• The shortage of donor's lungs for transplantation has led to a significant number of patient deaths. 
• The availability of laboratory-engineered, functional organs is expected to be a major advantage to cater to the growing demands of organ transplantation. 
• Decellularized solid organs can perform organ-specific functions for a short period, which indicates the potential for clinical use of engineered solid organs in the

Growing Research Activities in the Organ on Chip Devices Market 

• An increase in research activities on organ-on-chip devices to replace animal testing for new drug development is expected to boost the market growth in the upcoming years. 
• Multiple companies and research laboratories have received funding from private investors for their research-related activities. For instance, 
• In November 2018, the European Organ-on-Chip Society (EUROoCS) was officially launched to encourage and develop Organ-on-Chip research toward better health for everyone. The purpose of the Society is to encourage and develop Organ-on-Chip research, and to provide opportunities to share and advance the knowledge and expertise in this field towards better health for everyone. EUROoCS is one of the first outcomes of the Horizon 2020 project ORCHID (Organ-on-Chip In Development), which aims to create a roadmap for Organ-on-Chip technology and to build a network of all parties involved.
• In December 2016, Mimetas and the University of Pittsburgh received NIH SBIR Grant for the development of the liver-on-a-chip platform. 
• This chip can be used for the high-throughput discovery and development of drugs. 
• Small start-up companies receive investments either from government organizations or from other established companies. 

About Us:

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com